This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Serotonergic psychedelic: Difference between revisions
>Unity Bolded paper title |
>Unity Italicized journal names in literature section. Capitalized some paper titles. Added some DOI links. |
||
| Line 192: | Line 192: | ||
==Literature== | ==Literature== | ||
===Overview=== | ===Overview=== | ||
* Nichols, D. E. (2016). '''''Psychedelics.''''' Pharmacological | * Nichols, D. E. (2016). '''''Psychedelics.''''' ''Pharmacological Reviews'', 68(2), 264-355. https://doi.org/10.1124/pr.115.011478 | ||
* Johansen, P. Ø., & Krebs, T. S. (2015). '''''Psychedelics not linked to mental health problems or suicidal behavior: A population study. Journal of Psychopharmacology | * Johansen, P. Ø., & Krebs, T. S. (2015). '''''Psychedelics not linked to mental health problems or suicidal behavior: A population study'''''. ''Journal of Psychopharmacology'', 29(3), 270-279. https://doi.org/10.1177/0269881114568039 | ||
* Geyer, M. A., Nichols, D. E., & Vollenweider, F. X. (2009). '''''Serotonin- | * Geyer, M. A., Nichols, D. E., & Vollenweider, F. X. (2009). '''''Serotonin-Related Psychedelic Drugs.''''' ''Encyclopedia of Neuroscience''. https://doi.org/10.1016/b978-008045046-9.01160-8 | ||
* Nichols, C. D., & Sanders-Bush, E. (2001). '''''Serotonin | * Nichols, C. D., & Sanders-Bush, E. (2001). '''''Serotonin Receptor Signaling and Hallucinogenic Drug Action'''''. ''Heffter Rev Psychedelic Res'', 2, 73-79. https://web-beta.archive.org/web/20170110205041/https://heffter.org/docs/hrireview/02/chap5.pdf | ||
* Halberstadt, A. L. (2015). '''''Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.''''' Behavioral Brain Research, 277, 99–120. https://doi.org/10.1016/j.bbr.2014.07.016 | * Halberstadt, A. L. (2015). '''''Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.''''' ''Behavioral Brain Research'', 277, 99–120. https://doi.org/10.1016/j.bbr.2014.07.016 | ||
* Béïque, J. C., Imad, M., Mladenovic, L., Gingrich, J. A., & Andrade, R. (2007). '''''Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex.''''' Proceedings of the National Academy of Sciences, 104(23), 9870-9875. | * Béïque, J. C., Imad, M., Mladenovic, L., Gingrich, J. A., & Andrade, R. (2007). '''''Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex.''''' ''Proceedings of the National Academy of Sciences'', 104(23), 9870-9875. https://doi.org/10.1073/pnas.0700436104 | ||
* Winter, J. C., Fiorella, D. J., Timineri, D. M., Filipink, R. A., Helsley, S. E., & Rabin, R. A. (1999). '''''Serotonergic receptor subtypes and hallucinogen-induced stimulus control'''''. Pharmacology Biochemistry and Behavior, 64(2), 283-293. http://doi.org/10.1016/S0091-3057(99)00063-5. | * Winter, J. C., Fiorella, D. J., Timineri, D. M., Filipink, R. A., Helsley, S. E., & Rabin, R. A. (1999). '''''Serotonergic receptor subtypes and hallucinogen-induced stimulus control'''''. ''Pharmacology Biochemistry and Behavior'', 64(2), 283-293. http://doi.org/10.1016/S0091-3057(99)00063-5. | ||
* | * Nichols, D. E., & Nichols, C. D. (2008). '''''Serotonin Receptors'''''. ''Chemical Reviews'', 108(5), 1614-1641. https://doi.org/10.1021/cr078224o | ||
* Nichols, D. E. (2004). '''''Hallucinogens | * Nichols, D. E. (2004). '''''Hallucinogens'''''. ''Pharmacology & Therapeutics'', 101(2), 131-181. https://doi.org/10.1016/j.pharmthera.2003.11.002 | ||
* Vollenweider, F. X., & Kometer, M. (2010). '''''The | * Vollenweider, F. X., & Kometer, M. (2010). '''''The Neurobiology of Psychedelic Drugs: Implications for the Treatment of Mood Disorders'''''. ''Nature Publishing Group'', 11(9), 642–651. https://doi.org/10.1038/nrn2884 | ||
===Specific Examples=== | ===Specific Examples=== | ||